[go: up one dir, main page]

EP2223680A3 - Association de monosaccharides et d'agents desquamants et son utilisation en cosmétique - Google Patents

Association de monosaccharides et d'agents desquamants et son utilisation en cosmétique Download PDF

Info

Publication number
EP2223680A3
EP2223680A3 EP09181015.0A EP09181015A EP2223680A3 EP 2223680 A3 EP2223680 A3 EP 2223680A3 EP 09181015 A EP09181015 A EP 09181015A EP 2223680 A3 EP2223680 A3 EP 2223680A3
Authority
EP
European Patent Office
Prior art keywords
combination
monosaccharides
cosmetic use
exfoliating agents
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP09181015.0A
Other languages
German (de)
English (en)
Other versions
EP2223680A2 (fr
EP2223680B1 (fr
Inventor
Julien Laboureau
Jean-Thierry Simonnet
Pascal Portes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of EP2223680A2 publication Critical patent/EP2223680A2/fr
Publication of EP2223680A3 publication Critical patent/EP2223680A3/fr
Application granted granted Critical
Publication of EP2223680B1 publication Critical patent/EP2223680B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/87—Application Devices; Containers; Packaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne une composition, notamment cosmétique et/ou dermatologique, comprenant dans un milieu physiologiquement acceptable, l'association d'au moins un monosaccharide choisi parmi le mannose, le rhamnose et leur mélange, et d'au moins un agent desquamant. La présente invention concerne également l'utilisation d'une telle composition, ainsi qu'un dispositif la contenant.
EP09181015.0A 2008-12-30 2009-12-30 Association de monosaccharides et d'agents desquamants et son utilisation en cosmétique Active EP2223680B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0859149A FR2940609B1 (fr) 2008-12-30 2008-12-30 Association de monosaccharides et d'agents desquamants et son utilisation en cosmetique
US14475509P 2009-01-15 2009-01-15

Publications (3)

Publication Number Publication Date
EP2223680A2 EP2223680A2 (fr) 2010-09-01
EP2223680A3 true EP2223680A3 (fr) 2013-04-10
EP2223680B1 EP2223680B1 (fr) 2017-10-18

Family

ID=41055154

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09181015.0A Active EP2223680B1 (fr) 2008-12-30 2009-12-30 Association de monosaccharides et d'agents desquamants et son utilisation en cosmétique

Country Status (8)

Country Link
US (1) US20100168041A1 (fr)
EP (1) EP2223680B1 (fr)
JP (1) JP2010155835A (fr)
KR (1) KR101225205B1 (fr)
CN (1) CN101766549B (fr)
BR (1) BRPI0905234A2 (fr)
ES (1) ES2654043T3 (fr)
FR (1) FR2940609B1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2954123B1 (fr) * 2009-12-22 2012-02-03 Oreal Composition cosmetique de nettoyage comprenant un derive d'acide jasmonique et un tensioactif
FR2954122B1 (fr) * 2009-12-22 2012-02-10 Oreal Composition cosmetique comprenant un compose d'acide jasmonique
FR2973692B1 (fr) * 2011-04-05 2013-03-29 Oreal Composition cosmetique comprenant un compose d'acide cucurbique et un melange de polymeres sulfonique et acrylique
FR2973691B1 (fr) * 2011-04-05 2013-03-29 Oreal Composition cosmetique comprenant un compose d'acide cucurbique et un polymere acrylique semicristallin
FR2973693B1 (fr) * 2011-04-05 2013-03-29 Oreal Emulsion cosmetique comprenant un compose d'acide cucurbique
JP6100235B2 (ja) * 2011-04-05 2017-03-22 ロレアル ククルビン酸化合物と、スルホンおよびアクリルポリマーのブレンドとを含む化粧料組成物
FR2973694B1 (fr) * 2011-04-08 2013-03-29 Oreal Composition cosmetique comprenant un compose d'acide cucurbique et un melange de polymeres
FR2984725B1 (fr) * 2011-12-26 2014-01-31 Achaladanelle Utilisation d'une composition cosmetique ou dermocosmetique pour lutter contre les effets du tabac sur la peau
FR2988292B1 (fr) * 2012-03-23 2014-03-21 Oreal Composition cosmetique comprenant un compose d'acide cucurbique, un ether de sucre et un polymere acrylique semicristallin
FR2988291B1 (fr) * 2012-03-23 2014-03-21 Oreal Composition cosmetique comprenant un compose d'acide cucurbique, un ester de sucre polyoxyalkylene et un polymere acrylique semicristallin
WO2014095289A2 (fr) * 2012-12-20 2014-06-26 Unilever Plc Méthode de traitement du vieillissement capillaire
JP2014122191A (ja) * 2012-12-21 2014-07-03 L'oreal Sa 油、非イオン界面活性剤及びジャスモン酸誘導体を含む化粧品組成物
WO2014098264A1 (fr) 2012-12-21 2014-06-26 L'oreal Composition cosmétique
FR3004641B1 (fr) * 2013-04-17 2016-01-15 Oreal Composition cosmetique comprenant un compose d'acide cucurbique et une huile polaire (poly)oxyalkylenee
US9034833B1 (en) * 2013-12-20 2015-05-19 L'oreal Anti-aging composition containing high levels of a jasmonic acid derivative
KR101984195B1 (ko) * 2018-12-20 2019-05-30 주식회사 보타닉센스 자스몬을 유효성분으로 포함하는 항알러지, 아토피 피부염 개선, 또는 피부 재생용 조성물
JP7635905B2 (ja) 2020-11-20 2025-02-26 ポーラ化成工業株式会社 デスモグレイン減少剤

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0378936A2 (fr) * 1988-12-16 1990-07-25 L'oreal Utilisation de dérivés salicylés pour le traitement du vieillissement de la peau
EP0704210A2 (fr) * 1994-09-30 1996-04-03 L'oreal Utilisation d'une substance agoniste d'un récepteur associé à un canal chlore dans le traitement des rides
EP0756866A1 (fr) * 1995-07-31 1997-02-05 L'oreal Utilisation de dérives d'acide benzoique pour stimuler le processus de rénouvellement épidermique et traiter la peau
FR2739556A1 (fr) * 1995-10-04 1997-04-11 Oreal Utilisation de carbohydrates pour favoriser la desquamation de la peau
FR2767694A1 (fr) * 1997-09-02 1999-03-05 Oreal Systeme a base de derive d'acide phosphonique et de metabisulfite pour stabiliser l'acide ascorbique et composition contenant un tel systeme
FR2768623A1 (fr) * 1997-09-22 1999-03-26 Jean Noel Thorel Composition cosmetique et/ou dermatologique a usage topique pour le traitement des peaux grasses
EP1333022A2 (fr) * 2002-02-04 2003-08-06 L'oreal Compositions comprenant des dérivés du cyclopentane, et utilisation pour favoriser la desquamation
FR2853539A1 (fr) * 2003-04-08 2004-10-15 Ind E Com De Cosmeticos Natura COMPOSITION COSMETIQUE COMPRENANT LE FROPs ET LE RROPS, ET SON UTILISATION EN COSMETIQUE POUR UNE ACTION ANTI-VIEILLISSEMENT CUTANEE
FR2876283A1 (fr) * 2004-10-07 2006-04-14 Ind E Com De Cosmeticos Natura Composition cosmetique comprenant un compose saccharidique presentant un motif repete riche en rhamnose, et son utilisation en cosmetique pour une action anti- vieillissement cutane
US20070025933A1 (en) * 2004-04-01 2007-02-01 Industrial Farmaceutica Cantabria, S.A. Photoprotector and/or photoimmunoprotector compositions of the skin and their uses
WO2007101493A1 (fr) * 2006-03-07 2007-09-13 Henkel Ag & Co. Kgaa Agents cosmétiques contenant de la purine et/ou des dérivés ii de purine
FR2900574A1 (fr) * 2006-05-05 2007-11-09 Oreal Composition comprenant un agent tenseur et un compose saccharidique
WO2008068297A1 (fr) * 2006-12-06 2008-06-12 Pierre Fabre Dermo-Cosmetique Gel d'acide hyaluronique pour injection intradermique

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
FR2581542B1 (fr) 1985-05-07 1988-02-19 Oreal Compositions topiques destinees au traitement de la peau a base de derives de l'acide salicylique
FR2607498B1 (fr) 1986-12-01 1991-04-05 Oreal Nouveaux salicylates lipophiles d'ammoniums quaternaires, leur utilisation en cosmetique et en dermopharmacie
JP2796990B2 (ja) 1989-05-10 1998-09-10 株式会社資生堂 肌用化粧料
BR9001880A (pt) 1990-04-18 1991-11-12 Forjas Taurus Sa Mecanismo de desarme do cao aplicavel a pistolas semi-automaticas
EP0545002A1 (fr) 1991-11-21 1993-06-09 Kose Corporation Polymère de silicone, composition pâteuse et composition cosmétique du type eau-dans-l'huile le contenant
EP0570230B1 (fr) 1992-05-15 1998-09-30 Shiseido Company Limited Préparation externe pour la peau
FR2714831B1 (fr) 1994-01-10 1996-02-02 Oreal Composition cosmétique et/ou dermatologique contenant des dérivés d'acide salicylique et procédé de solubilisation de ces dérivés.
FR2722380A1 (fr) 1994-07-12 1996-01-19 Oreal Applicateur pour l'application d'un produit cosmetique liquide et ensemble de maquillage muni d'un tel applicateur
FR2726468B1 (fr) 1994-11-03 1996-12-13 Oreal Utilisation de derive de l'acide salicylique comme stabilisant d'une emulsion huile-dans-eau
US5811487A (en) 1996-12-16 1998-09-22 Dow Corning Corporation Thickening silicones with elastomeric silicone polyethers
FR2759370B1 (fr) 1997-02-12 2000-08-11 Oreal Nouveaux derives de l'acide salicylique et leur utilisation dans les compositions cosmetiques ou dermatologiques
FR2760641B1 (fr) 1997-03-13 2000-08-18 Oreal Emulsion huile-dans-eau stable, son procede de fabrication et son utilisation dans les domaines cosmetique et dermatologique
FR2762839B1 (fr) 1997-04-30 2001-05-11 Oreal Nouveaux derives de l'acide salicylique et leur utilisation dans une composition cosmetique et/ou dermatologique
JPH1160435A (ja) * 1997-08-20 1999-03-02 Shiseido Co Ltd 肌荒れ改善用化粧料
US6159479A (en) 1997-09-16 2000-12-12 L'oreal Hydrous salicylic acid solutions
EP1199956A1 (fr) 1999-07-09 2002-05-02 Bourjois Article pour l'application d'une composition topique et son procede de preparation
FR2796278B1 (fr) 1999-07-16 2002-05-03 Oreal Utilisation d'au moins un hydroxystilbene comme agent anti-glycation
FR2802425B1 (fr) 1999-12-21 2003-09-26 Oreal Utilisation d'un extrait d'au moins un vegetal de la famille des ericaceae comme agent anti-glycation
FR2802420B1 (fr) 1999-12-21 2002-02-22 Oreal Utilisation du 3,3', 5,5'-tetrahydroxystilbene comme agent anti-glycation
EP1138311A1 (fr) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
FR2810033B1 (fr) 2000-06-08 2004-04-30 Oreal Nouveaux composes de la famille des n-acylamino-amides, compositions les comprenant, et utilisations
FR2810548A1 (fr) 2000-06-26 2001-12-28 Oreal Utilisation d'ergothioneine et/ou de ses derives comme agent anti-glycation
FR2812544B1 (fr) 2000-08-02 2003-03-21 Oreal Utilisation d'au moins un extrait d'au moins un vegetal du genre salvia dans des compositions destinees a traiter les signes cutanes du vieillissement
FR2814950B1 (fr) 2000-10-05 2003-08-08 Oreal Utilisation d'au moins un extrait d'au moins un vegetal de la famille des ericaceae, dans des compositions destinees a traiter les signes cutanes du vieillissement
FR2818547B1 (fr) * 2000-12-22 2006-11-17 Oreal Nouveaux derives c-glycosides et utilisation
FR2819175B1 (fr) 2001-01-11 2003-02-21 Oreal Composition cosmetique et/ou dermatologique acide contenant un polymere amphiphile
US6866841B2 (en) * 2001-08-09 2005-03-15 Epatentmanager.Com Non-endocrine disrupting cytoprotective UV radiation resistant substance
FR2835525B1 (fr) 2002-02-04 2006-02-10 Oreal Nouveaux composes, compositions les comprenant et leur utilisation pour favoriser la desquamation
CA2501550A1 (fr) * 2002-10-15 2004-04-29 L'oreal Utilisation d'un amide ou d'un ester de sucre et d'acide gras dans le traitement et/ou la prevention de la peau seche
US7098189B2 (en) * 2002-12-16 2006-08-29 Kimberly-Clark Worldwide, Inc. Wound and skin care compositions
FR2850571B1 (fr) 2003-01-31 2006-07-07 Oreal Utilisation d'un derive d'acide(dihydro) jasmonique pour le traitement des peaux seches
FR2853543B1 (fr) 2003-04-11 2006-07-14 Oreal Composition sous forme d'emulsion h/e contenant des cires, et son utilisation dans le domaine cosmetique
US7365097B2 (en) * 2003-07-28 2008-04-29 L'oreal, S.A. Use of at least one (dihydro)jasmonic acid derivative as a desquamating agent
FR2858320B1 (fr) 2003-07-28 2005-09-02 Oreal Utilisation d'un derive d'acide (dihydro)jasmonique comme agent desquamant.
FR2863887B1 (fr) 2003-12-23 2008-05-16 Jean Noel Thorel Procede d'innoformulation d'une base galenique biocompatible
FR2877220B1 (fr) 2004-11-04 2008-10-10 Oreal Utilisation de composes d'uree pour lutter contre les signes du vieillissement cutane
FR2885524B1 (fr) * 2005-05-10 2007-08-10 Silab Sa Procede d'obtention d'un actif cosmetique exfoliant, principe actif obtenu et compositions associees
US20100009931A1 (en) 2006-05-05 2010-01-14 L'oreal Association of a tensor agent or device and a saccharide compound
FR2903001B1 (fr) * 2006-07-03 2008-09-26 Oreal Composition cosmetique associant un derive c-glycoside a un polymere associatif
KR100814493B1 (ko) * 2006-08-07 2008-03-18 (주)엠큐어 약물주사용 건
DE102006050984A1 (de) * 2006-10-26 2008-04-30 Henkel Kgaa Leistungsgesteigerte kosmetische Mittel mit Purin und/oder Purinderivaten

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0378936A2 (fr) * 1988-12-16 1990-07-25 L'oreal Utilisation de dérivés salicylés pour le traitement du vieillissement de la peau
EP0704210A2 (fr) * 1994-09-30 1996-04-03 L'oreal Utilisation d'une substance agoniste d'un récepteur associé à un canal chlore dans le traitement des rides
EP0756866A1 (fr) * 1995-07-31 1997-02-05 L'oreal Utilisation de dérives d'acide benzoique pour stimuler le processus de rénouvellement épidermique et traiter la peau
FR2739556A1 (fr) * 1995-10-04 1997-04-11 Oreal Utilisation de carbohydrates pour favoriser la desquamation de la peau
FR2767694A1 (fr) * 1997-09-02 1999-03-05 Oreal Systeme a base de derive d'acide phosphonique et de metabisulfite pour stabiliser l'acide ascorbique et composition contenant un tel systeme
FR2768623A1 (fr) * 1997-09-22 1999-03-26 Jean Noel Thorel Composition cosmetique et/ou dermatologique a usage topique pour le traitement des peaux grasses
EP1333022A2 (fr) * 2002-02-04 2003-08-06 L'oreal Compositions comprenant des dérivés du cyclopentane, et utilisation pour favoriser la desquamation
FR2853539A1 (fr) * 2003-04-08 2004-10-15 Ind E Com De Cosmeticos Natura COMPOSITION COSMETIQUE COMPRENANT LE FROPs ET LE RROPS, ET SON UTILISATION EN COSMETIQUE POUR UNE ACTION ANTI-VIEILLISSEMENT CUTANEE
US20070025933A1 (en) * 2004-04-01 2007-02-01 Industrial Farmaceutica Cantabria, S.A. Photoprotector and/or photoimmunoprotector compositions of the skin and their uses
FR2876283A1 (fr) * 2004-10-07 2006-04-14 Ind E Com De Cosmeticos Natura Composition cosmetique comprenant un compose saccharidique presentant un motif repete riche en rhamnose, et son utilisation en cosmetique pour une action anti- vieillissement cutane
WO2007101493A1 (fr) * 2006-03-07 2007-09-13 Henkel Ag & Co. Kgaa Agents cosmétiques contenant de la purine et/ou des dérivés ii de purine
FR2900574A1 (fr) * 2006-05-05 2007-11-09 Oreal Composition comprenant un agent tenseur et un compose saccharidique
WO2008068297A1 (fr) * 2006-12-06 2008-06-12 Pierre Fabre Dermo-Cosmetique Gel d'acide hyaluronique pour injection intradermique

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE GNPD [online] MINTEL; July 2006 (2006-07-01), "Exfoliating cream", XP002692267, Database accession no. 557651 *
DATABASE GNPD [online] MINTEL; October 2006 (2006-10-01), "Rich cream", XP002692269, Database accession no. 597642 *
DATABASE GNPD MINTEL; March 2008 (2008-03-01), "Lightening serum", XP002692268, Database accession no. 882731 *

Also Published As

Publication number Publication date
FR2940609B1 (fr) 2011-05-06
CN101766549B (zh) 2013-08-21
CN101766549A (zh) 2010-07-07
BRPI0905234A2 (pt) 2012-01-17
KR20100080438A (ko) 2010-07-08
FR2940609A1 (fr) 2010-07-02
ES2654043T3 (es) 2018-02-12
EP2223680A2 (fr) 2010-09-01
JP2010155835A (ja) 2010-07-15
KR101225205B1 (ko) 2013-01-23
US20100168041A1 (en) 2010-07-01
EP2223680B1 (fr) 2017-10-18

Similar Documents

Publication Publication Date Title
EP2223680A3 (fr) Association de monosaccharides et d'agents desquamants et son utilisation en cosmétique
FR2940613B1 (fr) Association de monosaccharides avec des filtres solaires et son utilisation en cosmetique
FR2940611B1 (fr) Association de monosaccharides et d'adenosine et son utilisation en cosmetique
Kuang et al. Novel approaches to the control of oral microbial biofilms
WO2008009379A3 (fr) Associations de principes actifs présentant des propriétés insecticides et acaricides
EP1987860A3 (fr) Film hydrosoluble cosmétique
EP2135603A3 (fr) Compositions et procédés pour augmenter la sensibilité à l'insuline
WO2005009352A3 (fr) Compostions antimicrobiennes contenant des combinaisons synergiques de composes d'ammonium quaternaire et d'huiles essentielles et/ou de leurs constituants
EP1889604A3 (fr) Utilisation d'un dérivé C-glycoside pour améliorer la fonction barrière de la peau
WO2006069998A3 (fr) Le compose glycopyrrolate dans des preparations cosmetiques
WO2004041269A3 (fr) Nouvel emploi pour composition pharmaceutique
EP2364692A3 (fr) Compositions comprenant au moins un derive de l'acide naphtoïque, du peroxyde de benzoyle et au moins un agent filmogene, leurs procedes de preparation, et leurs utilisations
WO2008015249A3 (fr) Composition cosmétique ou pharmaceutique d'acide hyaluronique
MY142329A (en) Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents.
EP1889642A3 (fr) Compositions cosmétiques associant un dérivé C-glycoside et un dérivé N-acylaminoamide
EP1864649A3 (fr) Composé de type bis-urée, composition le comprenant, utilisation et procédé de traitement cosmétique
WO2009121643A3 (fr) Agent de décoloration de fibres kératiniques contenant des particules revêtues
CA2726043A1 (fr) Composition de soin oral comprenant un composant adhesif
WO2007056236A3 (fr) Methodes de traitement anticancereux avec des formulations d'un compose de platine a base de lipides administree par voie intraveineuse
BR0001201A (pt) Composto ( poli ) tia-alcinóicos, composição cosmética, utilização de uma composição cosmética, utilização de um composto e composição farmacêutica
WO2008081095A3 (fr) Utilisation de l'acide gamma-aminobutyrique en tant qu'agent depigmentant
EP2017620A3 (fr) Diagnostics et thérapeutiques de maladies associées à la dipeptidyl-peptidase 1 (DPP1)
WO2006041538A3 (fr) Melange pour administration transdermique de composes a poids moleculaire faible et eleve
FR2915993B1 (fr) Nouveaux ligands agonistes des recepteurs pars, utilisation en medecine humaine ainsi qu'en cosmetique.
EP1944062A3 (fr) Composition cosmétique comprenant un polyuréthane cationique, un tensiooactif, et un corps gras et application au coiffage

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

AX Request for extension of the european patent

Extension state: AL BA RS

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 8/36 20060101ALI20130220BHEP

Ipc: A61Q 19/00 20060101ALI20130220BHEP

Ipc: A61Q 19/08 20060101ALI20130220BHEP

Ipc: A61K 8/60 20060101ALI20130220BHEP

Ipc: A61K 8/368 20060101ALI20130220BHEP

Ipc: A61K 8/365 20060101AFI20130220BHEP

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 8/365 20060101AFI20130227BHEP

Ipc: A61Q 19/00 20060101ALI20130227BHEP

Ipc: A61K 8/60 20060101ALI20130227BHEP

Ipc: A61Q 19/08 20060101ALI20130227BHEP

Ipc: A61K 8/36 20060101ALI20130227BHEP

Ipc: A61K 8/368 20060101ALI20130227BHEP

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

AX Request for extension of the european patent

Extension state: AL BA RS

17P Request for examination filed

Effective date: 20131010

RBV Designated contracting states (corrected)

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

17Q First examination report despatched

Effective date: 20140120

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20170515

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 937309

Country of ref document: AT

Kind code of ref document: T

Effective date: 20171115

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: FRENCH

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602009048900

Country of ref document: DE

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2654043

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20180212

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20171018

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 937309

Country of ref document: AT

Kind code of ref document: T

Effective date: 20171018

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171018

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171018

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180118

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171018

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171018

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180118

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171018

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171018

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171018

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180119

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180218

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602009048900

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171018

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171018

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171018

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171018

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171018

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171018

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171018

26N No opposition filed

Effective date: 20180719

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171018

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171230

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20171231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171230

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171018

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171231

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171231

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20091230

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171018

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171018

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171018

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171018

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20171018

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20240117

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20241105

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20241107

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20241111

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20241112

Year of fee payment: 16